UH-232

Quality 0.50 · 1 view · Updated 2 months ago

Chemical compound

title: "UH-232" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["2-aminotetralins", "dipropylamino-compounds", "methoxyphenethylamines", "stimulants", "phenol-ethers", "dopamine-antagonists", "dopamine-agonists"] description: "Chemical compound" topic_path: "general/2-aminotetralins" source: "https://en.wikipedia.org/wiki/UH-232" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Chemical compound ::

| Watchedfields = changed | verifiedrevid = 448227671 | IUPAC_name = (1S,2R)-5-Methoxy-1-methyl-2-(N,N-propylamino)tetralin | image = UH-232 Structure.svg | image_class = skin-invert-image | width = 200px

| tradename = | pregnancy_category = | legal_status = | routes_of_administration =

| bioavailability = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref = | CAS_number = 95999-12-5 | UNII_Ref = | UNII = QQYOR9S587 | ATC_prefix = none | ATC_suffix = | PubChem = 123696

| C=18 | H=29 | N=1 | O=1 | smiles = CC2C(N(CCC)CCC)CCc1c2cccc1OC

UH-232 ((+)-UH232) is a drug which acts as a subtype selective mixed agonist-antagonist for dopamine receptors, acting as a weak partial agonist at the D3 subtype, and an antagonist at D2Sh autoreceptors on dopaminergic nerve terminals. It causes dopamine release in the brain and has a stimulant effect, as well as blocking the behavioural effects of cocaine. It may also serve as a 5-HT2A receptor agonist, based on animal studies. It was investigated in clinical trials for the treatment of schizophrenia, but unexpectedly caused symptoms to become worse.

(+)-AJ76

The N-monopropyl derivative (+)-AJ76 is an active metabolite of UH-232 and has practically identical effects.

::figure[src="https://upload.wikimedia.org/wikipedia/commons/2/25/(+)-AJ76_structure.svg" caption="(+)-AJ76, CAS# 85378-82-1, [https://pubchem.ncbi.nlm.nih.gov/compound/13755572 13755572]"] ::

References

References

  1. (August 1995). "The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist". European Journal of Pharmacology.
  2. (November 1986). "(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists". Naunyn-Schmiedeberg's Archives of Pharmacology.
  3. (September 1993). "The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study". European Journal of Pharmacology.
  4. (August 1995). "Dopamine D3-preferring ligands act at synthesis modulating autoreceptors". The Journal of Pharmacology and Experimental Therapeutics.
  5. (January 1994). "Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo". European Journal of Pharmacology.
  6. (March 2001). "Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study)". Pharmacological Research.
  7. (July 2004). "The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats". Psychopharmacology.
  8. (August 1992). "Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232". Brain Research.
  9. (1998). "Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia". Journal of Neural Transmission.

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::

2-aminotetralinsdipropylamino-compoundsmethoxyphenethylaminesstimulantsphenol-ethersdopamine-antagonistsdopamine-agonists